| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.9B | $11.5B | $11.5B | $12.4B | $11.7B | $5.1B | $5.1B | $4.0B |
| Cost of Revenue | $7.0B | $7.4B | $7.8B | $8.3B | $7.9B | $3.0B | $3.0B | — |
| Gross Profit | $3.9B | $4.1B | $3.7B | $4.2B | $3.7B | $2.1B | $2.1B | $1.7B |
| R&D Expense | $0.7B | $0.7B | $0.6B | $0.6B | $0.6B | $0.4B | $0.3B | $0.3B |
| SG&A Expense | $1.8B | $2.0B | $1.8B | $1.8B | $1.7B | $0.9B | $0.9B | $0.7B |
| Operating Income | $-0.4B | $0.8B | $-2.1B | $-1.3B | $0.6B | $0.6B | $0.7B | $0.6B |
| Net Income | $-0.4B | $0.2B | $-2.6B | $-1.9B | $0.3B | $0.4B | $0.5B | $0.3B |
| EPS (Basic) | $-1.41 | $0.95 | $-10.05 | $-7.32 | $1.11 | $3.25 | $4.05 | $3.81 |
| EPS (Diluted) | $-1.41 | $0.95 | $-10.05 | $-7.32 | $1.10 | $3.21 | $4.00 | $3.79 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.5B | $28.7B | $31.0B | $35.4B | $39.7B | $13.6B | $13.3B | $12.9B |
| Current Assets | $5.6B | $8.0B | $6.3B | $7.4B | $7.0B | $3.1B | $2.9B | $2.9B |
| Cash & Equivalents | $0.6B | $0.5B | $0.7B | $0.5B | $0.7B | $0.6B | $0.6B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.9B | $4.3B | $3.8B | $3.7B | $3.6B | $1.9B | $1.6B | $1.1B |
| Stockholders' Equity | $14.2B | $13.9B | $14.6B | $17.7B | $21.1B | $6.3B | $6.2B | $6.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $1.1B | $1.4B | $0.4B | $1.4B | $0.7B | $0.7B | $0.4B |
| Investing Cash Flow | $2.3B | $0.3B | $0.6B | $0.7B | $-0.0B | $-0.2B | $-0.2B | $-5.0B |
| Capital Expenditures | $0.6B | $0.5B | $0.5B | $0.5B | $0.4B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-3.1B | $-1.6B | $-1.9B | $-1.2B | $-1.3B | $-0.5B | $-0.5B | $4.9B |